Skip to content
New: the dataset now includes 2,277 company profiles and every supplied review record. See the methodology →
◎ RankGlobal mapped
Verisim Life logo

Verisim Life

Predictive Analytics · MLOps & InfrastructureSan Francisco, USAFounded 2017

AI-first biotechnology company utilizing its BIOiSIM platform to predict patient outcomes and identify high-probability drug candidates early in the development cycle.

4.8
Average rating
13
Mapped reviews
100%
Profile coverage

Company & commercials

Primary category
Predictive Analytics
Team size
25-50 employees
Typical budget
$100K+
Primary industry
Healthcare & Life Sciences
Provider overview

A clear view of what Verisim Life does best.

Structured from supplied company information and mapped to RankGlobal's controlled AI and industry taxonomy.

Company profile
Predictive Analytics provider for Healthcare & Life Sciences

AI-first biotechnology company utilizing its BIOiSIM platform to predict patient outcomes and identify high-probability drug candidates early in the development cycle. RankGlobal maps its primary capability to Predictive Analytics within Predictive Analytics, with supporting relevance to Simulation & Scenario Modeling, MLOps. Its strongest supplied industry signals align with HealthTech Platforms.

See how this profile was mapped →
Primary AI category
Predictive Analytics
Strongest industry signal
Healthcare & Life Sciences
Engagement profile·$100K+·25-50 employees·Service
Mapped capabilities · 2 categories
Technology

Platforms, methods and technical signals

AI-driven BiosimulationDeep LearningChemical and Biological Modeling

Tools and platforms named in Verisim Life's supplied company profile.

Expertise

Named expertise on file

  • Biosimulation

    Biosimulation is the use of mathematical models and computer simulations to represent biological systems and processes, allowing researchers to predict how drugs, diseases, or environmental factors will interact with complex biological organisms without traditional trial-and-error.

    AI simulationComputer Vision
  • Predictive Pharmacology

    Predictive pharmacology uses computational models and data analytics to forecast how pharmaceutical compounds will behave in the body, including their efficacy, safety, and potential side effects, thereby optimizing the drug development process and clinical trial success.

    Predictive analysisPharmalogy
  • Machine Learning

    Machine learning is a field of artificial intelligence focused on building systems that can learn from data, identify patterns, and make decisions with minimal human intervention, utilizing various algorithms and statistical models to improve performance over time.

    DataInsights GatheringLearning
RankGlobal provider intelligence
Analyst brief

Mapped Evidence Report

A decision-support view of Verisim Life, built from mapped taxonomy signals, evidence confidence, commercial profile and reviews.

Primary feed set
Predictive Analytics
Compared with
946 providers
Evidence signals used
3 signals
Publication status
Published
Structured evidence signal
100/100
Strong evidence
58th percentile of 946 peers · peer median 100
Profile coverage100
Taxonomy density100
Review signal100
Peer benchmark
How the profile compares

Predictive Analytics among 946 published providers

Average rating4.83 · median 4.84
Mapped reviews13 · median 10
Profile completeness100% · median 100%
Taxonomy breadth14 · median 20
Signal radar
Multi-dimensional evidence
RatingReviewsCoverageBreadth
This profile (percentile) Peer median
Capability mix
Mapped category signal
Predictive Analytics100%
MLOps & Infrastructure76%

Imported mapping confidence for each category — not a share of work, revenue, or delivery volume.

Mapped industries
4 industries on the map
4
Healthcare & Life Sciences50%
Agriculture, Forestry & Food Systems17%
Manufacturing & Industrial17%
Personal, Household & Community Services17%

Share of mapped industry rows on the taxonomy map — not share of work or revenue.

Evidence mix
Mapping grades
Direct21% · 3
Supported43% · 6
Adjacent36% · 5

Imported mapping grades across 14 taxonomy mappings — not a search ranking.

RankGlobal analyst interpretation

What the mapped signals say

Verisim Life presents as a strong evidence profile for Predictive Analytics. It ranks in the 58th percentile of 946 published providers in Predictive Analytics, and 13 reviews back the commercial profile.

Current positioning: P58 evidence quality · P18 industry breadth
Strongest signals
Evidence-backed strength in Predictive Analytics is the profile's clearest signal in the mapped taxonomy.
Best user fit
Healthcare & Life Sciences buyers evaluating Predictive Analytics at a $100K+ engagement size.
Confirm before engagement
Confirm current delivery capacity directly — mapped signals reflect profile evidence, not live availability.
Client feedback signals
13
Reviews
4.8
Average rating
0
Publicly reshared
Published
Listing status
How this report is calculated →
Industry experience

Where this expertise is most relevant.

Industry mappings are organized by evidence strength so buyers can distinguish demonstrated alignment from broader search relevance.

6 mapped subindustries
Client feedback

What clients say.

Reviews and ratings published for this provider.

Accelerating the translation of our research to clinical success is a priority

Dr. Valerie Nicolas, Deputy to the Head of Translational Medicine

VeriSIM Life is an excellent partner on drug discovery and development

Sr. Dir. Translational Medicine Function

I found VSL's down-to-earth but competent approach very refreshing

Associate Director
5
Accelerating Drug Discovery via BIOSIM Mechanistic Modeling

VeriSIM Life's BIOSIM platform provides a unique and highly valuable approach to drug discovery. Their ability to integrate machine learning with mechanistic modeling allows us to better understand complex drug interactions and accelerate our development timelines significantly.

Dr. Matt Barnes
5
Predictive Accuracy for Promising Drug Candidate Discovery

The AI-driven insights provided by the BIOSIM platform have been instrumental in our research. The platform's predictive accuracy in drug delivery systems has allowed our team at USF to focus on the most promising candidates, saving both time and institutional resources.

Dr. Subhra Mohapatra
5
Early Pipeline De-Risking via Virtual Drug Development

By utilizing VeriSIM Life’s virtual drug development technology, we have been able to de-risk our pipeline early in the process. The platform effectively predicts clinical outcomes that traditional animal models often miss.

Senior Director of R&D (Global Pharma Client)
5
High-Fidelity Simulations for Human Clinical Success

The integration of mechanistic models with AI by VeriSIM is truly groundbreaking for the pharmaceutical industry. It addresses the 'valley of death' in drug development by providing high-fidelity simulations of how drugs will behave in humans.

Dr. Thomas J. Colacot
5
Moving from Preclinical to Clinical Strategy with Confidence

Working with the VeriSIM team has been a seamless experience. Their BIOSIM platform is sophisticated yet user-friendly for our scientists, helping us move from preclinical stages to clinical strategy with much higher confidence.

Head of Innovation (Mid-Size Biotech)
5
Optimizing Dosage and Toxicity via Virtual Trials

The accuracy of VeriSIM’s virtual trials is impressive. We have integrated their predictions into our workflow to optimize dosage selection and toxicity profiles for our clients' assets, yielding excellent results.

Scientific Officer (Contract Research Organization)

10 mapped reviews · 13 published quotes

Showing 9 of 13, ranked by display order then recency.

Rating distribution
5
10
4
0
3
0
2
0
1
0

Ratings aggregate 13 reviews at the average shown above.

Transparent profile intelligence

How RankGlobal maps this profile.

RankGlobal maps this profile against a controlled taxonomy. Mapping grades on capability and industry cards describe how the profile is classified. Source strength for ranking decisions follows the hierarchy published on Research— a mapping grade is not a claim of discoverability weight.

Tier 1 · Authoritative
Regulators, registries, certifications, signed client evidence.
Highest evidentiary weight
Tier 2 · Independent
Credible media, industry bodies, partner directories, third-party datasets.
Strong with attribution and recency
Tier 3 · Provider-controlled
Company site, case studies, press releases, structured submissions.
Accepted as a claim; verification raises weight
Tier 4 · Discovery-only
Directory listings, aggregations, and early discovery signals.
Used for discovery; weighted accordingly in ranking

Direct, Supported, Related and Adjacent appear on mapped cards as classification grades. They do not rank how discoverable a provider should be.

RankGlobal trust center →
Ready to evaluate this provider

Move from discovery to a focused conversation.

Your enquiry goes to the RankGlobal research team, not the provider's sales inbox. Sending it does not affect their ranking.

Before you reach out

What RankGlobal holds on file for Verisim Life, and the three things worth confirming directly once you're in touch.

Primary category
Predictive Analytics
Primary industry
Healthcare & Life Sciences
Typical budget
$100K+
Team size
25-50 employees
  1. 1
    Name the use case

    Say which Predictive Analytics problem you are evaluating, so the research team can route your message accurately.

  2. 2
    Pressure-test the budget band

    The $100K+ band on file is a profile-level figure. Ask what a scope like yours actually lands at.

  3. 3
    Ask for a reference

    Request a client reference in Healthcare & Life Sciences — the strongest industry signal on this profile.

Enquire about Verisim Life

Three fields. Anything longer belongs on the full contact page, linked below.